Biotechnology Sphingotec secures Series C financing Diagnostics company SphingoTec GmbH (Hennigsdorf, Germany) has successful closed a €5m Series C financing round led by Think.Health Ventures, with support from existing investors Brandenburg Kapital, HBM Healthcare Investments, NRW.BANK, and Wellington Partners. The raised capital will allow the company to reach profitability through partnerships and licence deals of its kidney function test penKid and […] Written by Thomas Gabrielczyk August 15, 2024August 15, 2024 Saving Bookmark this article Bookmarked
Programming cells: Revolutionizing genetic circuits with cutting-edge RNA tools Professor Jongmin Kim’s research team at POSTECH developed a new technology that improves the precision and integration density of synthetic genetic circuits. The research team led by Professor Jongmin Kim from the Department of Life Sciences at POSTECH, along with graduate students Hyunseop Goh and Seungdo Choi, has successfully developed the ‘Synthetic Translational Coupling Element […] Written by Admin December 23, 2024December 23, 2024 Saving Bookmark this article Bookmarked
Ionis gets a milestone approval; Another top FDA official to step down The clearance of Tryngolza gives Ionis its first wholly-owned, marketed medicine. Elsewhere, Robert Temple became the latest FDA leader to leave the agency, and two biotechs cut research deals. Written by BioPharma Dive staff December 23, 2024December 23, 2024 Saving Bookmark this article Bookmarked
Programming cells: Revolutionizing genetic circuits with cutting-edge RNA tools Professor Jongmin Kim’s research team at POSTECH developed a new technology that improves the precision and integration density of synthetic genetic circuits. The research team led by Professor Jongmin Kim from the Department of Life Sciences at POSTECH, along with graduate students Hyunseop Goh and Seungdo Choi, has successfully developed the ‘Synthetic Translational Coupling Element […] Written by Admin December 23, 2024December 23, 2024 Saving Bookmark this article Bookmarked
Ionis gets a milestone approval; Another top FDA official to step down The clearance of Tryngolza gives Ionis its first wholly-owned, marketed medicine. Elsewhere, Robert Temple became the latest FDA leader to leave the agency, and two biotechs cut research deals. Written by BioPharma Dive staff December 23, 2024December 23, 2024 Saving Bookmark this article Bookmarked
Columbia Climate School Delegates Reflect on COP29 – State of the Planet Last month, more than 50,000 people from 200 countries gathered for the 29th U.N. Climate Change Conference of the Parties (COP29) in Baku, Azerbaijan. For two weeks, global leaders, academics, scientists, public citizens, activists and nonprofit organizations from around the world came together to address the growing challenges and potential solutions to climate change. […] Written by Columbia Climate School December 23, 2024December 23, 2024 Saving Bookmark this article Bookmarked
Understanding PMDA Validation Rules v5.0 The Pharmaceuticals and Medical Devices Agency (PMDA) in Japan has always led the charge in ensuring the safety and efficacy of drug development. Their latest update, the PMDA Validation Rules version 5.0, which took effect on April 1, 2024, marks another significant step in this mission. Let’s break down what these new rules mean and […] Written by Admin July 10, 2024July 10, 2024 Saving Bookmark this article Bookmarked
Enhance Your SEND Submissions! Join PointCross on May 29th, 2024, at 12 PM EST / 9 AM PST for a must-attend webinar: The Most Common Issues in Preparing SEND. Ideal for professionals in data submission and regulatory compliance, this webinar offers valuable insights from our seasoned experts. Why Attend? Why PointCross? With over 10 years of experience and more […] Written by Admin May 23, 2024May 23, 2024 Saving Bookmark this article Bookmarked
